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Abstract 
Connexins, assembled as a hexameric connexon, form a transmembrane 
hemichannel that provides a conduit for paracrine signalling of small molecules 
and ions to regulate the activity and function of adjacent cells. When 
hemichannels align and associate with similar channels on opposing cells, they 
form a continuous aqueous pore or gap junction, allowing the direct transmission 
of metabolic and electrical signals between coupled cells. Regulation of gap 
junction synthesis and channel activity is critical for cell function, and a number of 
diseases can be attributed to changes in the expression/function of these 
important proteins. Diabetic nephropathy is associated with several complex 
metabolic and inflammatory responses characterised by defects at the molecular, 
cellular and tissue level. In both type 1 and type 2 diabetes, glycaemic injury of 
the kidney is the leading cause of end-stage renal failure, a consequence of 
multiple aetiologies, including increased deposition of extracellular matrix, 
glomerular hyperfiltration, albuminuria and tubulointerstitial fibrosis. In diabetic 
nephropathy, loss of connexin mediated cell–cell communication within the 
nephron may represent an early sign of disease; however, our current knowledge 
of the role of connexins in the diabetic kidney is sparse. This review highlights 
recent evidence demonstrating that maintained connexin-mediated cell–cell 
communication could benefit region-specific renal function in diabetic 
nephropathy and suggests that these proteins should be viewed as a tantalising 
novel target for therapeutic intervention. 
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Abbreviations 
α-Sma alpha Smooth muscle actin 
Cx  Connexin 
E-cadherin Epithelial cadherin 
EMT  Epithelial-to-mesenchymal transition 
ESRD  End-stage renal disease 
GJIC  Gap junction intercellular communication 
NCAD  Neural cadherin 
STZ  Streptozotocin 
ZDF  Zucker Diabetic Fatty 
ZL  Zucker Lean 
ZO-1  Zonula occludens 1 
 
Introduction 
Efficient renal function depends on cooperation between cells of the nephron and 
cells of the renal vasculature. Gap junctions permit direct intercellular transfer of 
small molecules and ions and are formed from the alignment of two connexons 
on adjoining cells [1]. Each connexon is composed of a hexameric assembly of 
connexins that make up a transmembrane pore called a hemichannel [1]. When 
hemichannels align with those on neighbouring cells they ‘dock’ to form an 
aqueous pore permitting the transmission of metabolic and electrical signals 
between coupled cells that facilitates cellular activity and synchronises tissue 
function. Most cells communicate with their immediate neighbours via gap 
junctions, and multiple connexin isoforms are expressed in the kidney [2]. In the 
kidney, multiple connexin isoforms are expressed [2]. However, whilst the 
presence of gap junctions has long been known, we have only recently begun to 
understand how connexins regulate renal function. Expressed in the renal 
vasculature, connexins have been demonstrated to contribute to the regulation of 
both GFR and renin secretion, thus suggesting a role for connexins in the 
regulation of blood pressure [3-4]. This critical function rightly warrants our 
attention. However, connexins are also highly expressed in tubular epithelium, 
where their role is far less certain. Elevated glucose in diabetes dramatically 
alters connexin expression, and it seems likely that changes in cell–cell 
communication play a critical role in the aetiology and pathophysiology of the 
disease [5-10]. 
In patients with diabetes, nephropathy represents the leading cause of end-stage 
renal disease (ESRD) and is the leading cause of entry into the renal 
replacement therapy programme. Sadly, renal complications of  diabetes account 
for approximately 21% of deaths in patients with type 1 and approximately 11% 
of deaths in patients with type 2 [11]. As the incidence of diabetes continues to 
increase, there is a pressing demand to identify future therapeutic targets to 
alleviate debilitating complications such as diabetic nephropathy. Associated with 
complex metabolic and inflammatory changes, diabetic nephropathy is 
characterised by defects at the molecular, cellular and tissue level [12]. 
Alterations in the expression of key candidate proteins pivotal to cell 
communication could contribute to the development and progression of key 
underlying pathologies of diabetic nephropathy. In the current article we review 
expression, localisation and function of connexin throughout the diabetic kidney 
and explore how glucose and its downstream pro-fibrotic mediators alter these 
important proteins. 
Connexins, connexons, gap junctions and hemichannels 
Connexins are a family of transmembrane proteins critical for intercellular 
communication. In humans, there are 21 genes known to be associated with the 
connexin family. Commonly designated by numerical suffixes referring to their 
molecular weight, the expression of these proteins may be ubiquitous (Cx32, 
Cx37, Cx40, Cx43 and Cx45) or tissue specific, e.g. Cx32 is expressed in 
numerous cells, including cardiac tissue, the kidney and hepatocytes, whilst 
Cx62 is expressed only in retinal tissue [13]). The biosynthesis and export of 
connexin polypeptides to the cell membrane is similar to other membrane bound 
proteins, with membrane insertion denoting topographic arrangement [14]. 
However, with a half-life of only a few hours, connexins are subjected to a 
continuous cycle of synthesis and degradation, a process that allows for acute 
regulation of channel activity and gap junction-mediated cell communication [14]. 
Sharing common structural features, connexins are composed of four 
transmembrane helices interconnected by two extracellular loops, one 
intracellular loop, and cytoplasmic -NH2 and -COOH terminal regions. Whilst the 
highly conserved -NH2 terminal tail incorporates a putative calmodulin-binding 
motif, which is necessary for membrane insertion, both the -NH2 terminal tail and 
-COOH terminal region are thought to play a central role in the regulation of 
channel conductance, being controlled by phosphorylation and post-translational 
modification [15, 16]. Phosphorylation of connexins can occur on either 
serine/threonine or tyrosine residues, and changes in conductance and/or 
permeability may have implications for the assembly, degradation and 
biosynthesis of gap junctions. [17] 
Gap junctions are formed through interaction between two connexons, or 
hemichannels on the membrane of adjacent cells. Hexameric structures 
comprised of six individual connexins, the resultant junction contains a 1-2 nm 
diameter aqueous pore, through which ions and small molecules, including Ca2+, 
ATP, cAMP, Na+ and IP3 pass [18]. Depending on the combination of connexin 
isoforms, they can either be homomeric or heteromeric (See Fig 1). As stand-
alone structures, hemichannels form when connexons are inserted into the 
membrane without association with another connexon on a neighbouring cell 
[18]. Hemichannels are also permeable to a variety of small metabolites and 
have been shown to contribute to paracrine signalling [19] 
 
The composite connexin isoforms of a given gap junction determine the 
selectivity of molecules able to migrate through the junction (i.e. its permeability), 
which, in turn, is determined by the diameter and charge of the pore formed. For 
example, Cx43 exhibits a greater affinity for AMP, ADP and ATP as compared 
with Cx32, whilst Cx32 has a 12-fold higher affinity for adenosine [20]. It is the 
ability of different isoforms to combine that lends itself to diversity in terms of 
permeability, selectivity and conductance, with conductance not just controlled by 
isoform homology but also by various stimuli, including pH, Ca2+ and post-
translational modification. It remains to be determined whether gap junction 
assembly and membrane insertion is random or site directed. What is known is 
that extracellular matrix (ECM) proteins, cadherins, integrins and laminins are 
required to facilitate their adhesion once inserted into the membrane [21-22]. 
The number of diseases attributed to mutations and single nucleotide 
polymorphisms in proteins involved in regulation of gap junction synthesis and 
channel activity suggest that functional gap junctions are critical for cell function 
[23]. Connexins have a role in ischaemia [24], inflammation [25] and both renin-
induced and essential hypertension [26-27]. Furthermore, the relationship 
between hyperglycaemia and a loss of gap junction expression is important in the 
progression and development of multiple microvascular complications in diabetes 
[28]. Effects of hyperglycaemia on gap junction intercellular communication 
(GJIC) have been examined in multiple tissue types, and there are reports that 
glucose decreases gap junction conductance and disrupts cellular homeostasis 
in various cell systems, including retinal pericytes [5], endothelial cells [6] and 
epithelial cells [29]. A glucose-evoked reduction of Cx43 in retinal capillaries of 
diabetic mice is observed to result in, increased apoptosis, loss of cell 
communication and a decline in pericyte and acellular capillary number [5]. Loss 
of Cx43 in vascular cells of diabetic rats impairs ventricular induction, suggesting 
that a loss of GJIC may also contribute towards cardiovascular complications of 
diabetes [30]. However instigated, it is clear that a glucose-induced loss of 
connexin-mediated cell-cell communication is important in the development of 
several facets of this debilitating metabolic disease. 
 
The role of connexins in the diabetic kidney 
In the kidney, multiple structural and functional changes occur in response to 
elevated levels of glucose, including those that occur in the glomerulus, 
tubulointerstitium and vasculature [12]. Structural abnormalities range from 
thickening of the glomerular basement membrane, hypertrophy, interstitial 
fibrosis and tubular atrophy [12]. Together, these changes contribute to 
glomerular hyperfiltration, albuminuria, systemic hypertension and loss of renal 
function [12]. Of the 21 connexin isoforms expressed in humans, nine are found 
in the tubular and vascular regions of the kidney (Cx26, Cx31, Cx30.3, Cx37, 
Cx32, Cx40, Cx43, Cx45 and Cx46) (for a review, see [2]). However, our 
understanding of how changes in gap junctions in the kidney facilitate 
progression of diabetes is limited. The following sections discuss our current 
knowledge for a role of connexins in the nephron, specifically, the renal 
vasculature, mesangium and podocytes. 
 
Vasculature Within endothelial cells of the rat afferent arteriole, Cx37, Cx40 and 
Cx43 are present, whilst post-glomerular vasculature appears to express only 
Cx43 [2]. For cells of the pre-glomerular vessels to communicate efficiently, they 
must be functionally coupled. Loss of synchronised cell communication may pre-
dispose to the development of early changes that underline the onset of diabetic 
nephropathy. This notion is supported by the presence of modified levels of both 
Cx40 and Cx43 in streptozotocin (STZ)-treated mice. In non-diabetic mice, Cx40 
is expressed on the endothelium from afferent arterioles, whilst Cx43 is localised 
to efferent arterioles. However, following STZ ablation of insulin-secreting 
pancreatic beta cells, expression of Cx40 was found to be increased in afferent 
arterioles and inside the glomerulus, whilst expression of endothelial Cx43 in 
efferent arterioles was decreased [7-8].  
The role of Cx40 in regulating blood pressure by modulating renin secretion is 
well documented. Renin is released by the juxtaglomerular apparatus and 
controls extracellular volume through changes in angiotensin II and mean arterial 
pressure [31]. Renin-producing cells are linked by Cx40-mediated gap junctions 
and are highly electrically coupled [32-33]. Knocking out the gene encoding Cx40 
(Gja5–/– mice) makes these animals hypertensive [32].  
It has previously been reported that renin-dependent hypertension experimentally 
induced by the clipping of a renal artery in the two-kidney, one-clip (2K1C) model 
is associated with a vessel-specific increase in the expression of Cx43 [34]. 
However, when Cx43 expression is repressed and replaced with Cx32, there is a 
marked reduction in renin secretion and mice are normotensive [35]. These 
findings have recently been questioned by Gerl M et al who, using mice with 
endothelium and renin cell-specific deletions of Cx43, failed to confirm a 
requirement for Cx43 in either renin expression or secretion in animals on either 
a normal salt diet or during chronic challenge of the renin system by pretreatment 
with a low-salt diet in the absence or presence of an ACE inhibitor [36]. 
In addition to controlling renin secretion, there is a link between connexins and 
glomerular hyperfiltration. Takenaka et al examined altered gap junction 
communication and abnormalities in renal haemodynamic in the Zucker Lean 
(ZL) rat and the Zucker Diabetic Fatty (ZDF) rat model of type 2 diabetes [37]. 
They reported that ZDF rats exhibit glomerular hyperfiltration with impaired 
autoregulation. The increase in GFR was linked to increased phosphorylation of 
Cx43 and reduced Cx37 expression in renin-secreting cells, suggesting that 
impaired GJIC in the juxtaglomerular apparatus mediates, or in part contributes 
to, altered renal autoregulation in the disease [37]. These data suggest that 
dysregulation of Cx37, Cx40 and Cx43 contribute to impaired autoregulation, 
glomerular hyperfiltration and dysregulated blood pressure homeostasis. 
 
Mesangium Ultrastructural and histochemical studies indicate the existence of a 
high density of gap junctions among mesangial cells, but little is known about 
their regulation. In diabetic nephropathy, mesangial cell proliferation has been 
proposed to play a role in the progression of glomerulosclerosis [38-39]. 
Glomerular mesangial cells are highly coupled by Cx43-containing gap junctions, 
with expression levels mirrored by GJIC [40]. Expression levels of Cx43 are 
downregulated in mesangial and endothelial cells of STZ-induced diabetic rats 
[41], whilst exposure of rat glomerular mesangium to platelet-derived growth 
factor evokes a phosphoinositide 3-kinase-dependent loss of Cx43-mediated 
GJIC [42]. This loss of cell communication, Yao et al propose, may in part 
contribute to the complex interplay of events that accompany mesangial cell 
proliferation in forms of renal disease, including diabetic nephropathy [42]. In 
support of these studies, recent findings by Morioka et al have confirmed that 
Cx40 expression in mesangial cells is related to mesangial cell regeneration, 
suggesting that connexin expression could be a therapeutic target for glomerular 
disease [43]. 
Mesangial expansion is a hallmark of early diabetic nephropathy and is regarded 
as the structural variable that best correlates with dysregulated GFR, proteinuria 
and hypertension [44]. Exposure of cultured glomerular mesangial cells to high 
glucose evokes arrest in the G1 (senescence) phase of the cell cycle [45]. Zhang 
et al confirmed that a glucose-evoked reduction in Cx43 accelerated the 
progression of mesangial cells through senescence, a state of arrested cell 
growth linked to mesangial cell hypertrophy in diabetic nephropathy [45]. In 
support of this, glucose-induced hypertrophy of mesangial cells was reversed by 
overexpressing Cx43 via the phosphatase and tensin 
homologue/Akt/mechanistic target of rapamycin (PTEN/Akt/mTOR) pathway [46]. 
These studies suggest that high glucose levels downregulate mesangial Cx43 
expression, inducing cell cycle arrest, inhibition of proliferation and promotion of 
protein synthesis and hypertrophy of the mesangium, thus highlighting the 
possibility of Cx43 as a future therapeutic target to both modulate cell 
hypertrophy and prevent mesangial expansion in diabetic nephropathy [46].  
Through interactions with numerous cell signalling and cell scaffold proteins, 
connexins are known to play a crucial role in cell adhesion, proliferation and 
migration. The carboxy tail of Cx43 interacts with c-Src, a non-receptor tyrosine 
kinase that can regulate cell proliferation. Activated c-Src phosphorylates Cx43 
on tyrosine residues Tyr265 and Tyr247, ultimately impairing and reducing GJIC 
[47-48]. Elevated levels of c-Src have been linked to the pathogenesis of diabetic 
nephropathy [49]. Furthermore, studies by Xie et al revealed that overexpression 
of Cx43 or inhibition of c-Src not only attenuates the upregulation of glucose-
induced intercellular adhesion molecule 1 (ICAM1), TGF-β1 and fibronectin 
expression in glomerular mesangial cells, but promotes and contributes to 
nuclear factor-κB activation, leading to renal inflammation [41].  
Abnormalities in renal NO generation have also been linked to the pathogenesis 
of renal disease in diabetes [50-52]. Whilst intrarenal NO production mediated 
primarily by constitutively released NO is increased in the early phases of 
diabetic nephropathy, a progressive decline in NO production and, specifically, 
NO bioavailability in the kidney has been observed with advancing renal failure 
[53]. A potential role of NO in the regulation of gap junction intercellular 
communication was suggested by Yao et al, who confirmed that increased NO 
augments Cx43-mediated GJIC; an effect they found to be dependent on protein 
kinase A [54]. Their observations were the first to suggest that diminished NO in 
diabetic nephropathy may in part mediate a loss of gap junction-mediated cell 
communication in mesangial cells. 
In addition to contributing to gap junction formation, uncoupled hemichannels 
permit local paracrine release of nucleotides (See Fig. 2) [19]. The gating of 
hemichannels is controlled by various physiological stimuli, including changes in 
membrane depolarisation, ionic concentration, mechanical stimulation and 
metabolic inhibition. 
Like gap junctions, hemichannels have a role in both cell survival and cell death 
[19]. Hemichannel-mediated ATP release has recently been linked to the 
progression and development of fibrosis in cardiac fibroblasts, data that suggests 
a potential pathophysiological role for dysregulated hemichannel-mediated ATP 
signalling [55]. Oxidative stress can open Cx43 hemichannels [56]. A recent 
study examined a role for boldine, an alkaloid with antioxidant, anti- 
inflammatory, and hypoglycaemic effects in the reversal of renal complications in 
the STZ-induced diabetic rat [57]. The study demonstrated that under resting 
conditions, mesangial hemi-channels had a low open-state probability. However, 
glucose, IL-1β and TNF-α all increased hemichannel activity, even at negative 
membrane potential and in the presence of extracellular divalent cations [57]. 
Furthermore, when exposed to high glucose and proinflammatory cytokines, 
mesangial cells exhibited reduced gap junction-mediated cell coupling, effects 
that were reversed by co-administration with boldine. Interestingly, cells cultured 
in high glucose in the presence of proinflammatory cytokines, exhibited a slight, 
but insignificant increase in Cx43 expression, whilst addition of boldine to the 
high glucose and proinflammatory cytokines led to a statistically significant 
elevation in Cx43 expression as compared with control. These results 
demonstrate that when exposed to a diabetic milieu, mesangial cells exhibit 
increased hemichannel activity and impaired gap junction-mediated cell 
communication—an effect abolished by co-incubation with boldine [57]. The 
authors suggest that the boldine-induced increase in Cx43 may account for 
newly synthesised gap junctions and explain the increase in coupled cells when 
co-administered with proinflammatory cytokines. Boldine may protect the kidney 
against oxidative stress by preventing hemichannel opening and ensuring cells 
remain successfully coupled to each other via gap junctions. 
 
Podocytes Impaired renal function in diabetic nephropathy is a consequence of a 
number of underlying pathologies that ultimately stem from the loss in viable 
nephrons. In the majority of cases, this process is initiated in response to 
podocyte injury. Whilst podocyte injury or podocyte loss in the renal glomerulus 
has been proposed as the crucial mechanism in the development of 
glomerulosclerosis, our understanding of how podocytes respond to injury is 
limited. Previous studies have shown that Cx43 is expressed on podocytes in 
both normal and diseased kidney tissue [58-59]. Initial studies by Yaoita et al 
reported increased Cx43 expression levels in the early to nephrotic stage of 
puromycin aminonucleoside-induced nephrosis in rats, an event they suggest 
may represent an early marker of podocyte injury [60]. Further to these findings, 
and given that oxidative stress mediates podocyte injury under a variety of 
pathological situations, Yan et al have reported that exposure of podocytes to 
puromycin evokes an increase in both NADPH oxidase 4 (NOX4) expression and 
superoxide generation [61]. Furthermore, inhibition of NADPH oxidase 
attenuated the puromycin-induced increase in Cx43 expression, whilst treatment 
of podocytes with several structurally different gap junction inhibitors significantly 
attenuated the cytotoxicity of puromycin, thus suggesting that NADPH oxidase-
mediated upregulation of Cx43 contributes to podocyte injury [61]. Finally, failure 
of Lucifer yellow dye to transfer between parietal epithelial cells of the Bowman’s 
capsule, led to the suggestion that podocytes may respond to injury as an 
integrated epithelium on a glomerulus rather than individually as a separate cell 
[60]. 
Our knowledge of podocyte gap junctions and their role in diabetic kidney 
disease is sparse. Studying renal biopsies and podocytes from patients with type 
2 diabetes and comparing these with nephrectomised kidney samples from 
individuals with localised neoplasm or minor glomerular abnormalities, Sawai et 
al [62] observed a loss of Cx43 expression in patients with overt nephropathy. To 
retain renal function, the loss of podocytes and glomerular hypertrophy in 
diabetic nephropathy must be compensated for. To this end, podocytes migrate 
and extend their cell body over the glomerular basement membrane depleted of 
functioning podocytes. Sawai et al proposed that a loss of Cx43 and 
redistribution away from points of cell–cell contact, impaired podocyte cell 
communication and contributed to the loss of barrier function leading to 
albuminuria [62]. They hypothesised that Cx43 directly interferes with tight 
junctions and cytoskeletal proteins, ultimately impairing slit diaphragm 
components essential for the selective filtering process. As a consequence of this 
important study, Cx43 staining may represent an easy and convenient means of 
assessing podocyte damage and renal function in diabetic nephropathy. 
 
Connexins, cell–cell communication and renal fibrosis 
Diabetic nephropathy is histologically characterised by increased expression of 
interstitial matrix components and an accumulation of the ECM in both the 
glomerular mesangium and tubular interstitum, together culminating in excessive 
renal scarring and a decline in excretory function [12]. Renal fibrosis presents as 
glomeruosclerosis, tubulointerstitial fibrosis, infiltration of inflammatory mediators 
and the activation of alpha-smooth muscle actin-positive myofibroblasts [63-64]. 
Of these, tubulointerstitial fibrosis is the key pathology underlying diabetic 
nephropathy, with fibrosis and the subsequent loss of cell function being a 
predictive marker for ESRD. Understanding the signals that regulate the 
deposition of fibrotic material in the interstitium is important for developing site-
directed therapies that may help alleviate this damage. 
Central to tubulointerstitial fibrosis is tubular epithelial-to-mesenchymal transition 
(EMT), or the trans-differentiation of tubular epithelial cells into myofibroblasts 
[63]. In diabetic nephropathy, EMT occurs as cells attempt to avoid apoptosis in 
the presence of high glucose. Ultimately, cells undergo a number of 
morphological and phenotypic changes in which they lose classic epithelial 
characteristics in exchange for markers more commonly associated with a 
mesenchymal phenotype. This trans-differentiation occurs at four distinct stages. 
The pivotal step of EMT is denoted by a loss of epithelial (E)-cadherin and the 
subsequent loss of cell–cell adhesion. This is further accompanied by a loss of 
epithelial proteins central to tight junction formation, e.g. claudin and the zonula 
occludens protein (ZO-1), whilst cytoskeletal remodelling is accompanied by the 
loss of cytokeratin expression, replaced by the intermediate filament protein 
vimentin and alpha-smooth muscle actin. Together, these morphological changes 
result in loss of cell adhesion and tubular basement membrane disruption which, 
when combined with expression of fibroblast specific protein 1, results in the 
production of a newly defined group of cells that exhibit enhanced motility and 
increased proliferative and contractile capacity. These cells migrate from the 
tubular basement membrane into the interstium where they reside as fibrotic 
mediators, an event that leads to increased deposition of the ECM [64]. 
Tissue integrity is maintained by cell–cell and cell–substrate (ECM) adhesion. 
Adhesion is multifunctional, providing structural support and a link between the 
cell and its environment. Loss of adhesion precedes loss of function. In diabetic 
nephropathy, impaired E-cadherin mediated cell–cell adhesion represents a 
pivotal step in early proximal tubular injury [63-64]. Cadherins help form the multi-
protein adherens junction that links cell–cell contact to the actin cytoskeleton and 
various signalling molecules. In epithelial cells connexins co-localise with 
cadherins and, consequently, gap junctions form close to the site of intercellular 
adhesion, where they mediate GJIC [21]. Inhibiting cadherin-based cell adhesion 
inhibits gap junction assembly and impairs cell–cell communication [65], while 
upregulation of E-cadherin-dependent cell–cell contacts increased GJIC in 
mouse epidermal cells [66]. In human proximal tubule cells, glucose-evoked 
increases in TGF-β1 reduced Cx43-mediated GJIC by reducing cell–cell 
adhesion [67]. Interestingly, some type 2 diabetic patients have been found to 
have elevated levels of visfatin, and this adipokine has recently been shown to 
inhibit expression of both Cx26 and Cx43 in the human kidney (HK2) proximal 
tubule cell line [68].  
In wound healing, deposition of the ECM is a response to renal injury, whilst 
excessive matrix deposition is a hallmark of fibrosis and occurs when cells of the 
nephron over compensate in their attempt to maintain function [69]. Therefore, a 
tight balance between synthesis and breakdown of matrix proteins is required. 
One mechanism of control is through regulation of collagen and matrix 
metalloproteinase (MMP) production [70]. Loss of this regulation can tip the 
balance from repair to injury, culminating in a build-up of fibrotic material and 
scar formation. Recent studies examining the role of connexins in wound healing 
in human diabetic fibroblasts and keratinocytes suggest that an increase in cell 
motility may occur as a consequence of decreasing both gap junction and 
hemichannel activity [71]. Furthermore, keratinocytes exhibit a loss of Cx43 
expression at 24-48 h during the normal healing process as cells become 
migratory in an attempt to close the wound [72]. These studies suggest that a 
loss of connexin expression may facilitate wound healing, an observation that 
may have dramatic implications for scar formation and fibrosis in the diabetic 
kidney. In an STZ-induced mouse model, cell migration is delayed until the 
connexins are downregulated [73]. Connexins form partnerships with multiple 
adhesion and structural proteins, e.g. Cx43 forms a complex with ZO-1, β-catenin 
and N-cadherin, proteins likely to influence cell adhesion and wound healing. Not 
surprisingly, knockdown of Cx43 in conjunction with the cell adhesion protein N-
cadherin accelerates cell migration in a scratch wound healing assay [74]. These 
data, which are consistent with those presented by Hills et al [67] confirming a 
link between loss of Cx expression and impaired E-cadherin-mediated cell 
adhesion in the human proximal tubule, support the notion that both Cx43 and 
adhesion proteins may represent therapeutic targets for improved wound repair 
and in alleviating tubulointerstital fibrosis, where loss of connexin expression in 
the renal tubule may not only lead to impaired cell communication but may 
facilitate increased cell migration. In accordance with morphological and 
phenotypic changes linked to early tubular injury in diabetic nephropathy, loss of 
connexin-mediated communication and increased motility may facilitate the 
migration of cells into the interstitium, where they can reside as newly defined 
fibrotic mediators.  
Contrary to the above, recent studies by Abed et al propose an opposite effect of 
impaired Cx expression. Having confirmed that biopsies of patients with chronic 
kidney disease exhibit elevated levels of Cx43, they also confirmed that, when 
interbred with RenTg mice, a genetic model of hypertension-induced chronic 
kidney disease, Cx43+/- mice exhibit a marked decrease in cell adhesion 
markers, which leads to reduced monocyte infiltration and interstitial renal 
fibrosis. In addition, functional and histological markers such as albuminuria and 
glomerulosclerosis were also ameliorated [75]. These differences in both 
expression and function however may of course be region specific and may be 
explained by an absence of hyperglycaemia.   
Do connexins protect against diabetic nephropathy? 
In the cortical collecting duct, efficient and appropriate re-uptake of sodium 
depends upon an integrated response of the ductal epithelium to changes in 
osmolarity. This in turn relies on connexin-mediated coordination of cellular 
activity [76-77]. Abnormal sodium reabsorption has been linked to the 
development of hypertension in both renal disease and diabetic nephropathy. 
Cells of the human cortical collecting duct express Cx43 and the transient 
receptor potential cation channel subfamily V member 4 (TRPV4) ion channels 
[78]. Mechano-sensitive TRPV4 channels regulate cell volume via Ca2+-
dependent mechanisms [79] and help maintain epithelial integrity and ductal 
function in response to osmotic challenge by high glucose. Inability to resolve 
osmotic changes has serious repercussions for the transport of Na+ and the 
development of secondary hypertension associated with renal diseases, such as 
diabetic nephropathy. Cx43 mediates GJIC between cells of the collecting duct, 
and high glucose (25 mmol/l) actually increases this expression and 
consequently improves cell–cell communication [80]. These data suggest a 
pivotal role for Cx43-mediated gap junctions in the synchronisation of activity 
between cells of the cortical collecting duct in response to stimuli that mimic the 
osmotic and physical challenges associated with high glucose. To date, there is a 
wealth of information relating loss of gap junction expression and impaired cell 
communication to various secondary complications of diabetes in multiple tissue 
types [28]. In all instances, reduced Cx expression was shown to evoke 
pathophysiological changes through impaired GJIC, which ultimately facilitated 
loss of cell communication and impaired function. However, in the cortical 
collecting duct, it is interesting to speculate that glucose-evoked increases in Cx 
expression and enhanced cell communication may protect the duct from further 
glucose-induced damage, including alterations in re-absorptive capacity, 
associated with more established, progressive diabetic nephropathy. 
 The functional consequences of these data remain to be confirmed, and it should 
be noted that some cells change their Cx expression pattern in culture [81]. 
Investigators should bear this in mind when extrapolating in vitro cell work to the 
clinical scenario. 
 
Conclusion 
To help synchronise activity and coordinate function within different regions of 
the nephron, connexins mediate direct gap junction-associated cell–cell 
communication as well as local paracrine intercellular signalling from 
hemichannels. In diabetic nephropathy, these small proteins play a vital role in 
orchestrating an integrated functional response against osmotic, fibrotic and 
metabolic assault. This review outlines growing evidence that connexins offer a 
viable future therapeutic target for the control and treatment of a number of renal 
diseases, including diabetic nephropathy. 
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Figure Legends 
 
Fig. 1 Gap Junction assembly may be homotypic or heterotypic. Gap junction 
formation occurs when connexons on adjacent cells align to form either a 
homotypic or heterotypic structure. Whether the connexon is defined as 
homomeric or heteromeric is dependent on the nature of the connexin isoform 
present. If a gap junction comprises two identical hexameric structures, then the 
channel is rendered homotypic. However, if the composition of each aligning 
connexon is different as a consequence of multiple connexin isoforms, then the 
channel is defined as heterotypic 
 Fig. 2 Connexins are the building blocks of both gap junctions and 
hemichannels. Alignment of connexons on adjacent cells (Cell 1 and Cell 2) 
permits electrical coupling and direct gap junction-mediated cell–cell 
communication of small ions and molecules (e.g. Ca2+ and cAMP, black dots). 
When connexons lack a binding partner on a neighbouring cell, e.g. Cell 3, 
undocked hemichannels provide a conduit for the efflux of these small cytosolic 
molecules and ions into the intercellular space immediately surrounding the cell 
(e.g. ATP, red dots). The limited volume of this intercellular space allows the 
concentration of agonists to increase (↑[ATP]e) to levels capable of evoking a 
receptor-mediated response on adjacent cells expressing the appropriate 
receptor, e.g. Cell 2 expressing P2Y purinoreceptors. This local paracrine 
transfer of information provides an alternative route for synchronising cellular 
activity  
 
 
